quantumbiopharma.com (QNTM): Price to Earnings Adjusted for Growth Rate
Quantum BioPharma Ltd (QNTM) revenues are based on fragmented assets split between dietary supplements and biotech. The PEG ratio on this GURU.Markets chart illustrates this trend, where 0.00 determines the latest valuation metric. Profit prospects rely on neurobiology patents, while success depends on management's ability to effectively commercialize products amid reforms.
Metric breakdowns and analytics for Quantum BioPharma Ltd (QNTM)
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- shareholders' equity book value data:
- business debt structure and liquidity details:
Debt to Capital Quantum BioPharma Ltd|QNTM - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital quantumbiopharma.com|QNTM - Company Debts|Debt to Net Assets Quantum BioPharma Limited|QNTM - Company Long-Term Liabilities|Company Short-Term Debts Quantum BioPharma|Quick Ratio quantumbiopharma.com
- earnings and market ratios statistics:
QNTM - Company Net Income|Net Profit Forecast Quantum BioPharma Ltd|QNTM - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Quantum BioPharma Corp|QNTM - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Quantum BioPharma Limited|QNTM - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Quantum BioPharma|QNTM - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months quantumbiopharma.com|QNTM - Earnings growth in current year|Net earnings per share growth forecast for next year Quantum BioPharma Ltd
Fundamental company analysis:Quantum BioPharma Ltd
Geopolitical instability and reagent logistics disruptions are creating significant barriers for the biomedical developments of Quantum BioPharma Ltd (QNTM). The PEG ratio compares the market value of earnings with their growth rate, revealing undervalued assets. An analysis of the growth-normalized P/E allows for a determination of whether earnings dynamics offset current market risks. Values below one signal the potential for a sharp surge in quotes. This confirms the fundamental resilience of the business amid uncertainty.
Who Quantum BioPharma Ltd competes with
HLN (Haleon PLC) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Kenvue Corp KVUE|Verona Pharma Inc. (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|ligand.com - Company Value to Earnings Growth Ratio|AMRX: PEG Multiple|Perrigo Company PLC - Growth-Adjusted Payback Ratio|ALVO (Alvotech Corp) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Liquidia Inc. LQDA|Price/Earnings to Growth Ratio Galapagos NV (GLPG)|ANIP (anipharmaceuticals.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio MannKind MNKD|Price to Net Income Growth Ratio Amphastar Pharmaceuticals Inc|PCRX: Price/Earnings to Growth Multiple|SPRY - PEG Multiple|TBPH: PEG Multiple|aquestive.com (AQST) - PEG Multiple|Price/Earnings to Growth Ratio scPharmaceuticals, Inc.|Growth-Adjusted P/E Ratio TECX (Tectonic)|Price/Earnings to Growth Multiple TNXP (Tonix Pharmaceuticals Inc.)|Company Value to Earnings Growth Ratio SXTC|Eupraxia Pharmaceuticals Inc. - Price/Earnings to Growth Multiple|PEG Multiple bioharvest.com BHST|EXOZ - Price/Earnings to Growth Ratio|Oramed Pharmaceuticals (ORMP) - Price/Earnings to Growth Multiple|ENTX (enterabio.com) - Price/Earnings to Growth Multiple|MindWalk Therapeutics - Growth-Adjusted Payback Ratio|ABVC (ABVC BioPharma) - PEG Multiple|Price/Earnings to Growth Ratio CPIX|PEG Multiple FGEN|Growth-Adjusted Market Cap to Net Income Telomir Pharmaceuticals Inc|Price/Earnings to Growth Ratio Rani Therapeutics Holdings, Inc. RANI|Synergy CHC Corp. (SNYR) - Price to Earnings Adjusted for Growth Rate|RLYB - Price/Earnings to Growth Ratio|Market Cap to Earnings and Growth Ratio LEXX|PULM: PEG Multiple|Pheton Holdings - Growth-Adjusted Payback Ratio|APM (Aptorum Group Ltd) - PEG Multiple|PEG Multiple Lyra Therapeutics Inc|Price/Earnings to Growth Ratio Impact BioMedical Inc (IBO)|TNFA (tnfpharma.com) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio cbdMD YCBD|PRFX - Price/Earnings to Growth Multiple|Auris Medical - PEG Multiple|LIPO - PEG Multiple|OPTN (OptiNose, Inc.) - Price/Earnings to Growth Multiple|pieris.com - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Procaps|Price/Earnings to Growth Ratio PTPI|Price/Earnings to Growth Multiple QLI (Qilian International Holding Group Limited)|Company Value to Earnings Growth Ratio SLRN|PEG Multiple TFFP (TFF Pharmaceuticals)
